Can RNA Expression Profiles Help Predict Risk of Recurrence in High-intermediate Risk Endometrial Cancer Patients?

被引：0
|
作者：
Goldsberry, W. [1 ]
Kamal, M. Z. [1 ]
Davis, A. M. [1 ]
Londono, A. I. [1 ]
Foxall, M. E. [1 ]
Katre, A. A. [1 ]
Roane, B. M. [1 ]
Martinez, A. [1 ]
Arend, R. C. [1 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 158卷 / 01期
关键词：
D O I：
10.1016/j.ygyno.2020.04.022
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
21
引用
收藏
页码：E10 / E10
页数：1
相关论文
共 50 条
  • [1] Can RNA expression profiles help predict risk of recurrence in high-intermediate risk endometrial cancer patients?
    Kamal, M. Z.
    Davis, A. M.
    Londono, A. I.
    Foxall, M.
    Katre, A. A.
    Roane, B. M.
    Martinez, A.
    Kim, B.
    Arend, R. C.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 262 - 262
  • [2] High-intermediate risk endometrial cancer: Can gene expression predict recurrence?
    Tawfik, Cindy
    Kim, Beomjy
    Londono, Angelina
    Katre, Ashwini A.
    Della Manna, Deborah L.
    Huh, Warner King
    Yang, Eddy Shih-Hsin
    Bevis, Kerri S.
    Straughn, John Michael
    Leath, Charles A.
    Arend, Rebecca Christian
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Identifying a molecular profile to predict the risk of recurrence in high-intermediate risk endometrial cancer
    Arend, Rebecca C.
    Scalise, Carly B.
    Dholakia, Jhalak
    Kamal, Maahum Z.
    Thigpen, Haley B.
    Crossman, David
    Huh, Warner K.
    Leath, Charles A., III
    CANCER MEDICINE, 2021, 10 (22): : 8238 - 8250
  • [4] Using gene expression and DNA mutations to predict recurrence in high-intermediate risk endometrial cancer
    Martinez, A. Alba
    Londono, A.
    Shelton, K. A.
    Montgomery, A. M.
    Kim, B.
    Katre, A. A.
    Huh, W.
    Yang, E. S.
    Bevis, K. S.
    Straughn, J. M., Jr.
    Leath, C. A., III
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 186 - 186
  • [5] Genomic profiling of high-intermediate risk endometrial cancer to differentiate recurrence risk.
    Dobbin, Zachary Christopher
    Landers, Emily E.
    Londono, Angelina I.
    Katre, Ashwini A.
    Yang, Eddy Shih-Hsin
    Boone, Jonathan David
    Bevis, Kerri S.
    Straughn, John Michael
    Huh, Warner King
    Leath, Charles A.
    Crossman, David
    Alvarez, Ronald David
    Arend, Rebecca Christian
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Lymph node dissection in intermediate and high-intermediate risk endometrial cancer
    Ozgul, Nejat
    Akgor, Utku
    Salman, Mehmet Coskun
    Kuru, Oguzhan
    Gultekin, Murat
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (06) : 1146 - 1152
  • [7] Stratification of intermediate-risk endometrial cancer patients into groups at high risk or low risk for recurrence based on tumor gene expression profiles
    Ferguson, SE
    Olshen, AB
    Viale, A
    Barakat, RR
    Boyd, J
    CLINICAL CANCER RESEARCH, 2005, 11 (06) : 2252 - 2257
  • [8] Heterogeneity of patients with high-intermediate and high-risk endometrial cancer included in prospective trials
    Praiss, A. M.
    Huang, Y.
    Collado, F. Khoury
    Tergas, A. I.
    Melamed, A.
    Hou, J. Y.
    St Clair, C. M.
    Wright, J. D.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 69 - 70
  • [9] Clinical relevance of high-intermediate risk endometrial cancer according to European risk classification
    Rychlik, Agnieszka
    Zapardiel, Ignacio
    Baquedano, Laura
    Maestre, Maria Angeles Martinez
    Querleu, Denis
    Martin, Pluvio J. Coronado
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (10) : 1528 - 1534
  • [10] Adjuvant docetaxel and carboplatin chemotherapy for patients with high-intermediate and high-risk endometrial cancer
    Kudaka, W.
    Nakasone, T.
    Arakaki, Y.
    Nakamoto, T.
    Wakayama, A.
    Kinjyo, Y.
    Taira, Y.
    Nagai, Y.
    Kaneshima, I.
    Nishihira, K.
    Aoki, Y.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (06) : 917 - 920
12345